Section 2: Selection, Procurement and Distribution
2SPD-026
MANAGEMENT OF DRUG SHORTAGES (submitted in 2019)
2SPD-025
APPLICATION OF HAZARD VULNERABILITY ANALYSIS TO EVALUATE THE RISK LEVEL OF MEDICINE SHORTAGES (submitted in 2019)
2SPD-024
SHORTAGES OF MEDICINES IN HOSPITAL: RESULTS OF A SURVEY ON THE PERCEPTION OF HEALTH WORKERS IN THE WARDS VSV REAL WORLD (submitted in 2019)
2SPD-023
HOW MUCH DOES FALSIFIED MEDICINES DIRECTIVE ACTUALLY COSTS? DETAILED COST EVALUATION OF SERIALISATION IN A REPRESENTATIVE SAMPLE OF HUNGARIAN HOSPITAL PHARMACIES (submitted in 2019)
2SPD-022
DRUG SHORTAGES AND DRUG UNAVAILABILITY: ANALYSIS FROM AN ITALIAN HOSPITAL (submitted in 2019)
2SPD-021
SURVEY OF DRUG SHORTAGES IN HUNGARIAN HOSPITALS
2SPD-020
IMPACT OF MEDICINE SHORTAGES ON AN OUTPATIENT CLINIC OF A GENERAL HOSPITAL (submitted in 2019)
2SPD-019
FOUR YEARS OF SHORTAGES REGARDING THE ANATOMIC, THERAPEUTIC AND CHEMICAL CLASSIFICATION (submitted in 2019)
2SPD-018
FOUR YEAR STUDY OF DRUGS SHORTAGES IN TWO PUBLIC HOSPITALS (submitted in 2019)
2SPD-017
IMPACT OF THE IMPLEMENTATION OF THE FALSIFIED MEDICINES DIRECTIVE AT THE LISBON PORTUGUESE INSTITUTE OF ONCOLOGY (FG, EPE) (submitted in 2019)
2SPD-016
FUTURE DISTRIBUTION MODELTS FOR PAID PHARMACEUTICALS: THE PATIENT'S PERSPECTIVE (submitted in 2019)
2SPD-015
COST OF STOCKOUT. A GROWING PROBLEM (submitted in 2019)
2SPD-014
EVALUATING THE METHODOLOGICAL QUALITY OF PIVOTAL CLINICAL TRIALS´S PUBLICATIONS FOR ORPHAN DRUGS AUTHORISED IN 2018. ARE THEY RELIABLE? (submitted in 2019)
2SPD-013
APPLICATION OF THE ABC ANALYSIS METHOD FOR OPTIMIZING THE STOCK MANAGEMENT OF MEDICAL DEVICES IN COMMON USE (submitted in 2019)
2SPD-012
COST MINIMISATION STUDY IN SEVERE ASTHMA TREATMENT (submitted in 2019)
